Financial Year |
September 30 2021 |
Monetary Funds |
1,987,244,340.44 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
500,063,277.31 |
Advances to Suppliers |
63,505,892.08 |
Other Receivables |
58,836,880.58 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
54,764,267.38 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
-- |
Total Current Assets |
2,830,747,902.27 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
586,342,786.11 |
Under-construction Projects |
75,489,820.97 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
569,552,661.06 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
264,297,568.21 |
Deferred Income Tax Assets |
76,690,464.46 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,572,373,300.81 |
Total Assets |
4,403,121,203.08 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
99,050,000.00 |
Accounts Payable |
167,278,605.87 |
Accounts Received In Advance |
8,885,536.94 |
Employee Compensation Payable |
230,734,357.68 |
Taxes Payable |
37,463,106.56 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
441,160,203.82 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
32,156,004.69 |
Sub-Total of Current Liabilities |
1,264,081,697.75 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
184,499,957.34 |
Special Payable |
-- |
Estimatied Liabilities |
67,011,884.85 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
406,294,266.91 |
Total Liabilities |
1,670,375,964.66 |
Paid-In Capital(Or Share Stock) |
1,014,306,324.00 |
Capital Surplus |
1,439,413,475.07 |
Surplus Reserve |
294,765,104.40 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-524,403,673.22 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,732,745,238.42 |
Owner's Equity(Stockholder's Equity) |
2,732,745,238.42 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,403,121,203.08 |